NR1H4 and Pruritus: As pruritus induction has been observed in all clinical trials testing other FXR agonists, pruritus appears to be an FXR-mediated class effect rather than a specific adverse effect unique to OCA.11,28 Other than a higher risk for constipation, gastrointestinal AEs were also not increased with OCA.